Aegle Therapeutics Company
Aegle Therapeutics Corporation, a regenerative medicine company isolating extracellular vesicles ("EVs") from allogeneic bone marrow derived mesenchymal stem cells (MSCs) to treat severe dermatological conditions, including burns and epidermolysis bullosa (“EB”).
Technology:
Other
Industry:
Cell Therapy
Headquarters:
Florida, United States
Founded Date:
2013
Investors Number:
25
Total Funding:
$175.2M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Debt Financing
Register and Claim Ownership